Scout | Neuropathological Interactions Between COVID-19 and ADRD (R01

This opportunity is no longer accepting applications.

grant

Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)

This grant opportunity invites R01 applications for studies using animal, cell culture, or human tissue models to explore how COVID-19 impacts Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD). Proposals should include models or experimental outcomes that incorporate AD/ADRD risk factors, pathologies, or comorbidities. Research can focus on: 1) how COVID-19 affects cent…

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $500,000

Funding Amount: $500,000

Dates

Submission Deadline: October 4, 2024

Application Window Closes: October 4, 2024

Opportunity Released: April 12, 2024

Open for Submission: April 12, 2024

Keywords

COVID-19

Alzheimer's disease

ADRD

CNS pathology

cognitive outcomes

neuropathology

animal models

cell culture

human tissue models

comorbidities.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers